JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.

Jiangxi Synergy Pharmaceutical Co., Ltd.

300636

CNE100002P83

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
10.04 ^CNY	+1.72%		-2.90%	-4.74%

05-20	Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments	CI
05-20	Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023	CI

Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Dividend for 2020

April 23, 2021 at 03:34 pm

Jiangxi Synergy Pharmaceutical Co., Ltd. approved cash dividend/10 shares (tax included) of CNY 0.85000000 for 2020 at the Annual General Meeting held on 22 April 2021.

Latest news about Jiangxi Synergy Pharmaceutical Co., Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments	05-20	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023	05-20	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	04-24	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) added to S&P Global BMI Index	23-09-18	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023	23-05-18	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-16	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2022	23-04-24	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.1 billion in funding	22-06-30	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 05 July 2022	22-06-29	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Dividend for 2021	22-05-16	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2021	22-04-25	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-05	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Announces Final Cash Dividend for the Year 2020, Payable on May 18, 2021	21-05-12	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Dividend for 2020	21-04-23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Election Directors and Supervisors	21-04-23	CI

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

Duration

Period

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

More charts

Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangxi Synergy Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.04 CNY

Average target price

9.3 CNY

Spread / Average Target

-7.37%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.	-4.74%	582M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.42%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.19%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals